Abraxis BioScience to Present at the Bank of America 2007 Health Care Conference
23 Maio 2007 - 9:00AM
Business Wire
Abraxis BioScience, Inc. (NASDAQ:ABBI), an integrated, global
biopharmaceutical company, today announced that Patrick
Soon-Shiong, M.D., chairman and chief executive officer, will
present a company overview at the Bank of America 2007 Health Care
Conference on Wednesday, May 30, 2007 at 2:00 p.m. PT at the Four
Seasons Hotel in Las Vegas, Nevada. Interested parties can listen
to the presentation through a live webcast at the Abraxis
BioScience Web site, www.abraxisbio.com. Listeners are encouraged
to visit the Web site at least 15 minutes prior to the start of the
scheduled presentation to register, download and install any
necessary audio software. For those unable to listen to the live
webcast, the presentation will be archived on the same Web site for
approximately 14 days. About Abraxis BioScience, Inc. Abraxis
BioScience, Inc. is an integrated global biopharmaceutical company
dedicated to meeting the needs of critically ill patients. The
company develops, manufactures and markets one of the broadest
portfolios of injectable products and leverages revolutionary
technology such as its nab� platform to discover and deliver
breakthrough therapeutics that transform the treatment of cancer
and other life-threatening diseases. The first FDA approved product
to use this nab platform, ABRAXANE�, was launched in 2005 for the
treatment of metastatic breast cancer. Abraxis trades on the Nasdaq
Global Market under the symbol ABBI. For more information about the
company and its products, please visit www.abraxisbio.com.
Abraxis Bioscience (MM) (NASDAQ:ABBI)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Abraxis Bioscience (MM) (NASDAQ:ABBI)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
Notícias em tempo-real sobre Abraxis Bioscience (MM) da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de Abraxis BioScience, Inc.